NPM1 MRD-994
Test info
NPM1 MRD
994
LAB994
MSO
NPM1 minimal residual
Minimal residual disease levels assessed by NPM1 mutation
Minimal residual disease levels assessed by NPM1 mutation
- To track and identify previously detected NPM1 mutations in post treatment follow up samples, a multiplex master mix targeting exon 12 on the NPM1 gene is used to amplify DNA extracted from a patient sample.
- Identify tumor-specific markers for post-treatment monitoring.
- Monitor and evaluate disease recurrence.
Specimen
EDTA whole blood
5.0 mL
Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting
Do not spin
Lavender (EDTA), 4mL
ACD-A whole blood
EDTA bone marrow
ACD-A bone marrow
EDTA bone marrow
ACD-A bone marrow
Bone marrow: 3 mL
Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting
Do not spin
ACD-A whole blood:
Yellow ACD-A
Bone marrow:
Lavender (EDTA), 4mL
Yellow ACD-A
Refrigerated (preferred) - 7 days
Ambient - 72 hours
Frozen - NO
Performance
Laboratories for Personalized Molecular Medicine (LabPMM) LLC (NMP1 MRD NGS Assay): R-NX
7 - 14 days
Next-Generation Sequencing (NGS)
Clinical and Interpretive info
An interpretive report will be issued
Billing
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
0049U
Tracking
03/25/2019
03/05/2024
03/05/2024